IDiyas

For the Inventor, By the Inventor

Tsukuba, Japan

Genji Iwasaki

USPTO Granted Patents = 11


Average Co-Inventor Count = 5.2

ph-index = 2

Forward Citations = 23(Granted Patents)


Location History:

  • Takarazuka, JP (1993)
  • Ibaraki, JP (2006)
  • Ibaraki Pref., JP (2008 - 2010)
  • Tsukuba, JP (2006 - 2011)

Company Filing History:

goldMedal10 out of 3,923 
 
Novartis Ag
 patents
silverMedal1 out of 6 
 
Japat Limited
 patents

Years Active: 1993-2011

Loading Chart...
Loading Chart...
11 patents (USPTO):
1. 8034810 - Arylsulfonamido-substituted hydroxamic acid derivatives (2011-10-11),
2. 7820818 - Heteroaryl nitrile derivatives (2010-10-26),
3. 7659293 - α-Amino-N-hydroxy-acetamide derivatives (2010-02-09),
4. 7544688 - Hetereoaryl nitrile derivatives (2009-06-09),
5. 7531546 - Spiro-substituted pyrrolo[2,3-D]pyrimidines as cathepsin inhibitors (2009-05-12),
6. 7452886 - Pyrrolo pyrimidines as agents for the inhibition of cystein proteases (2008-11-18),
7. 7291634 - α-amino-N-hydroxy-acetamide derivatives (2007-11-06),
8. 7138432 - Arylsulfonamido-substituted hydroxamic acid derivatives (2006-11-21),
9. 7112611 - 1g(α)-amino-N-hydroxy-acetamide derivatives (2006-09-26),
10. 7112589 - Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases (2006-09-26),
11. 5248655 - 1,2,4-triazole-3-yl-alkane- or cycloalkane-phosphonic acids as active (1993-09-28),

Title: Unveiling the Innovative Legacy of Genji Iwasaki

Introduction: Genji Iwasaki, a brilliant inventor hailing from Tsukuba, Japan, has carved a path of innovation with a distinguished portfolio of 11 patents. His groundbreaking inventions have significantly impacted the technological sphere, cementing his status as a visionary in the realm of invention.

Latest Patents: Genji Iwasaki's latest patents showcase his prowess in developing cutting-edge solutions for complex medical conditions. One notable patent encompasses arylsulfonamido-substituted hydroxamic acid derivatives that act as MMP2 inhibitors, offering potential treatment for a range of conditions such as inflammation, rheumatoid arthritis, and tumors. Another significant patent involves heteroaryl nitrile derivatives that serve as potent inhibitors of cathepsin K, with applications in addressing various medical conditions like osteoporosis and inflammation.

Career Highlights: Throughout his career, Genji Iwasaki has made significant contributions to renowned companies such as Novartis AG and Japat Limited. His innovative spirit and commitment to pioneering solutions have propelled these organizations to new heights in the realm of medical advancements and technological innovation.

Collaborations: Genji Iwasaki has collaborated closely with esteemed colleagues such as Kenji Hayakawa and Junichi Sakaki, pooling their expertise and creativity to push the boundaries of invention further. These collaborative efforts have led to the development of groundbreaking solutions that have the potential to revolutionize the medical and technological landscape.

Conclusion: In conclusion, Genji Iwasaki emerges as a trailblazing inventor whose visionary inventions have reshaped the technological landscape. His dedication to innovation, coupled with his collaborative spirit and profound impact on the medical field, cements his legacy as a true pioneer in the world of invention.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…